Beyond that, BiotechDueDIligence has combed through the SEC filings from Friday night of Christmas Eve eve. Find all the biotech-related news below.
NWBO Northwest Biotherapeutics: implications of NASDAQ delisting for debt
ILIU Interleukin Genetics: Director resignation
CLSN Celsion: $15m shelf
CTXR Citius Pharma: files annual report 10-K
OVAS Ova Sciences: details on restructuring and executive departures
CBMX CombiMatrix: Director resignation
CTIC CTI Biopharma: response to information request from Italian securities regulator
LION Lion Biotechnologies: $100m shelf
AUPH Aurinia Pharma: prospectus supplement
AMRS Amyris: offering prospectus - plus joint venture details
CPRX Catalyst Pharma: prospectus
PULM Pulmatrix: delisting notice
RNVA Rennova Health: offering prices
NBIX Neurocrine Biosciences: CFO resigns
KBIO Kalobios: stock purchase agreement - plus debt agreement
IMMY Imprimis Pharma: stock purchase agreement
ONS Oncobiologics: note agreement
SIGA Siga Technologies: Chapter 11 bankruptcy final decree
DVAX Dynavax: terminates note agreement
TIG TiGenix: conversion price of notes adjusted for IPO
ARRY Array BioPharma: term and revolving loan agreeement